References
- Santiago MA , EsquirolJL , FernándezRN , MaletáPD. Aminoglucósidos: mirada actual desde su historia. Rev. Cubana Pediatr.79, 1–10 (2007).
- Palomino J , PachónJ. Aminoglucósidos. Enferm. Infecc. Microbiol. Clin.21, 105–115 (2003).
- Turnidge J . Pharmacodynamics and dosing of aminoglycosides. Infect. Dis. Clin. North Am.17, 503–528 (2003).
- Krause KM , SerioAW , KaneTR , ConnollyLE. Aminoglycosides: an overview. Cold Spring Harb. Perspect. Med.6, 1–18 (2016).
- Bland CM , PaiMP , LodiseTP. Reappraisal of contemporary pharmacokinetic and pharmacodynamic principles for informing aminoglycoside dosing. Pharmacotherapy38, 1229–1238 (2018).
- Eric B , WingardJR. Overview of neutropenic fever syndromes. login.ezpbibliotecas.udec.cl/login?qurl=https://www.uptodate.com%2fcontents%2foverview-of-neutropenic-fever-syndromes%3fsearch%3dOverview%2520of%2520neutropenic%2520fever%2520syndrome%26source%3dsearch_result%26selectedTitle%3d1∼150%26usage_type%3ddefault%26display_rank%3d1#H477941076 (Accessed 18october2021).
- Legrand M , MaxA , PeigneVet al. Survival in neutropenic patients with severe sepsis or septic shock. Crit. Care Med.40, 43–49 (2012).
- Gudiol C , Aguilar-GuisadoM , AzanzaJRet al. Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Network for Research in Infectious Diseases (REIPI) and the Spanish Society of Haematology and Haemotherapy (SEHH) on the management of febrile neutropenia in patients with hematological malignancies. Enferm. Infecc. Microbiol. Clin.38, 174–181 (2020).
- Averbuch D , OraschC , CordonnierCet al. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica98, 1826–1835 (2013).
- Ministerio de Salud C . Leucemia en mayores de 15 años. Serie Guías Cínicas Minsal1–43 (2010).
- Pérez-Blanco JS , SáezFernández EM , CalvoMV , LanaoJM , Martín-SuárezA. Amikacin initial dosage in patients with hypoalbuminaemia: an interactive tool based on a population pharmacokinetic approach. J. Antimicrob. Chemother.75, 2222–2231 (2020).
- Fisman DN , KayeKM. Once-daily dosing of aminoglycoside antibiotics. Infect. Dis. Clin. North Am.14, 475–487 (2000).
- Gonzalez LS , SpencerJP. Aminoglycosides: a practical review. Am. Fam. Physician58, 1811–1820 (1998).
- Micromedex IBM . Dosing/administration – adult dosing amikacin. www.micromedexsolutions.com/micromedex2/librarian/PFDefaultActionId/evidencexpert.DoIntegratedSearch?navitem=topHome&isToolPage=true# (Accessed 7May2021).
- Molina J , CorderoE , PalominoJ , PachónJ. Aminoglycosides and polymyxins. Enferm. Infecc. Microbiol. Clin.27, 178–188 (2009).
- Pagkalis S , MantadakisE , MavrosMN , AmmariC , FalagasME. Pharmacological considerations for the proper clinical use of aminoglycosides. Drugs71, 2277–2294 (2011).
- Kapusnik JE , HackbarthCJ , ChambersHF , CarpenterT , SandeMA. Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental Pseudomonas pneumonia. J. Infect. Dis.158, 7–12 (1988).
- Gerber AU , VastolaAP , BrandelJ , CraigWA. Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo model. J. Infect. Dis.146, 691–697 (1982).
- Rozdzinski E , KernWV , ReichleAet al. Once-daily versus thrice-daily dosing of netilmicin in combination with β-lactam antibiotics as empirical therapy for febrile neutropenic patients. J. Antimicrob. Chemother.31, 585–589 (1993).
- Torfoss D , ArneHøiby E , TangenJNet al. Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial. J. Antimicrob. Chemother.59, 711–717 (2007).
- Kiel PJ , LoM , StockwellD , PatelGP. An evaluation of amikacin nephrotoxicity in the hematology/oncology population. Am. J. Ther.15, 131–136 (2008).
- Calandra T . Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. Ann. Intern. Med.119, 584–593 (1993).
- Mavros MN , PolyzosKA , RafailidisPI , FalagasME. Once versus multiple daily dosing of aminoglycosides for patients with febrile neutropenia: a systematic review and meta-analysis. J. Antimicrob. Chemother.66, 251–259 (2011).